Neuronal Cbl controls biosynthesis of insulin-like peptides in Drosophila melanogaster

Molecular and Cellular Biology

Volumn 32, Issue 18, 2012, Pages 3610-3623

  Yu, Yue ^a   Sun, Ying ^a   He, Shengqi ^a   Yan, Cheng ^a   Rui, Liangyou ^b   Li, Wenjun ^a   Liu, Yong ^a  

^a Chinese Academy of Sciences   (China)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INSULIN LIKE PEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPEPTIDE; PROTEIN CB1; PROTEIN KINASE B; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DOWN REGULATION; DROSOPHILA MELANOGASTER; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE INTERACTION; GENE SILENCING; GENETIC CONSERVATION; INSULIN SYNTHESIS; LIFESPAN; LONGEVITY; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PEPTIDE SYNTHESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STARVATION; UPREGULATION;

ANIMALS; BRAIN; CARBOHYDRATE METABOLISM; CELL LINE; DOWN-REGULATION; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; INSULIN; INSULIN-SECRETING CELLS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LONGEVITY; MALE; NEURONS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-CBL; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STARVATION;

DROSOPHILA MELANOGASTER; RATTUS;

EID: 84866391685     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00592-12     Document Type: Article

References (70)

1. Ahmed Z, Smith BJ, Pillay TS. 2000. The APS adapter protein couples the insulin receptor to the phosphorylation of c-Cbl and facilitates ligandstimulated ubiquitination of the insulin receptor. FEBS Lett. 475:31-34.
2. Bachmann-Gagescu R, et al. 2010. Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity. Genet. Med. 12:641-647.
3. Barbieri M, Bonafe M, Franceschi C, Paolisso G. 2003. Insulin/IGF-IFIG signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am. J. Physiol. Endocrinol. Metab. 285:E1064- E1071.
4. Brogiolo W, et al. 2001. An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Curr. Biol. 11:213-221.
5. Broughton SJ, et al. 2005. Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands. Proc. Natl. Acad. Sci. U. S. A. 102:3105-3110.
6. Cao C, Brown MR. 2001. Localization of an insulin-like peptide in brains of two flies. Cell Tissue Res. 304:317-321.
7. Chen H, et al. 2011. PDGF signalling controls age-dependent proliferation in pancreatic [bgr]-cells. Nature 478:349-355.
8. Cheng CL, Gao TQ, Wang Z, Li DD. 2005. Role of insulin/insulin-like growth factor 1 signaling pathway in longevity. World J. Gastroenterol. 11:1891-1895.
9. Choi Y, et al. 2002. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Oncogene 21:5289-5300.
10. Duan L, Reddi AL, Ghosh A, Dimri M, Band H. 2004. The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling. Immunity 21:7-17.
11. Ettenberg SA, et al. 1999. cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors. Mol. Cell Biol. Res. Commun. 2:111-118.
12. Freeman M. 1996. Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye. Cell 87:651-660.
13. Gabay L, et al. 1996. EGF receptor signaling induces pointed P1 transcription and inactivates Yan protein in the Drosophila embryonic ventral ectoderm. Development 122:3355-3362.
14. Galisteo ML, Dikic I, Batzer AG, Langdon WY, Schlessinger J. 1995. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J. Biol. Chem. 270:20242-20245.
15. Giannakou ME, Partridge L. 2007. Role of insulin-like signalling in Drosophila lifespan. Trends Biochem. Sci. 32:180-188.
16. Hakonen E, et al. 2011. Epidermal growth factor (EGF)-receptor signalling is needed for murine beta cell mass expansion in response to high-fat diet and pregnancy but not after pancreatic duct ligation. Diabetologia 54:1735-1743.
17. Hime GR, Dhungat MP, Ng A, Bowtell DD. 1997. D-Cbl, the Drosophila homologue of the c-Cbl proto-oncogene, interacts with the Drosophila EGF receptor in vivo, despite lacking C-terminal adaptor binding sites. Oncogene 14:2709-2719.
18. Hirasaka K, et al. 2007. Deficiency of Cbl-b gene enhances infiltration and activation of macrophages in adipose tissue and causes peripheral insulin resistance in mice. Diabetes 56:2511-2522.
19. Huang F, Gu H. 2008. Negative regulation of lymphocyte development and function by the Cbl family of proteins. Immunol. Rev. 224:229-238.
20. Ikeya T, Galic M, Belawat P, Nairz K, Hafen E. 2002. Nutrientdependent expression of insulin-like peptides from neuroendocrine cells in the CNS contributes to growth regulation in Drosophila. Curr. Biol. 12:1293-1300.
21. Khoo S, et al. 2003. Regulation of insulin gene transcription by ERK1 and ERK2 in pancreatic beta cells. J. Biol. Chem. 278:32969-32977.
22. Lam TK. 2010. Neuronal regulation of homeostasis by nutrient sensing. Nat. Med. 16:392-395.
23. Lawrence M, Shao C, Duan L, McGlynn K, Cobb MH. 2008. The protein kinases ERK1/2 and their roles in pancreatic beta cells. Acta Physiol. 192: 11-17.
24. Lawrence MC, McGlynn K, Park BH, Cobb MH. 2005. ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter. J. Biol. Chem. 280:26751-26759.
25. Lee KS, et al. 2008. Drosophila short neuropeptide F signalling regulates growth by ERK-mediated insulin signalling. Nat. Cell Biol. 10:468-475.
26. Levkowitz G, et al. 1999. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol. Cell 4:1029-1040.
27. Levkowitz G, et al. 1998. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12: 3663-3674.
28. Li L, et al. 2011. Cbl-regulated Akt and ERK signals are involved in beta-elemene-induced cell apoptosis in lung cancer cells. Mol. Med. Report 4:1243-1246.
29. Liu G, Rogers J, Murphy CT, Rongo C. 2011. EGF signalling activates the ubiquitin proteasome system to modulate C. elegans lifespan. EMBO J. 30:2990-3003.
30. Liu J, DeYoung SM, Hwang JB, O'Leary EE, Saltiel AR. 2003. The roles of Cbl-b and c-Cbl in insulin-stimulated glucose transport. J. Biol. Chem. 278:36754-36762.
31. Liu J, Kimura A, Baumann CA, Saltiel AR. 2002. APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes. Mol. Cell. Biol. 22:3599-3609.
32. Meisner H, et al. 1997. Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development. Mol. Cell. Biol. 17:2217-2225.
33. Miettinen P, Ormio P, Hakonen E, Banerjee M, Otonkoski T. 2008. EGF receptor in pancreatic beta-cell mass regulation. Biochem. Soc. Trans. 36:280-285.
34. Miettinen PJ, et al. 2006. Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal beta-cell growth. Diabetes 55:3299-3308.
35. Miyake S, Mullane-Robinson KP, Lill NL, Douillard P, Band H. 1999. Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinasebinding domain. J. Biol. Chem. 274:16619-16628.
36. Moghal N, Sternberg PW. 1999. Multiple positive and negative regulators of signaling by the EGF-receptor. Curr. Opin. Cell Biol. 11:190-196.
37. Molero JC, et al. 2004. c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action. J. Clin. Invest. 114:1326-1333.
38. Molero JC, et al. 2006. Genetic ablation of the c-Cbl ubiquitin ligase domain results in increased energy expenditure and improved insulin action. Diabetes 55:3411-3417.
39. Morris DL, Cho KW, Rui L. 2010. Critical role of the Src homology 2 (SH2) domain of neuronal SH2B1 in the regulation of body weight and glucose homeostasis in mice. Endocrinology 151:3643-3651.
40. Morris DL, Cho KW, Zhou Y, Rui L. 2009. SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins. Diabetes 58: 2039-2047.
41. Pai LM, Barcelo G, Schupbach T. 2000. D-cbl, a negative regulator of the Egfr pathway, is required for dorsoventral patterning in Drosophila oogenesis. Cell 103:51-61.
42. Pai LM, et al. 2006. Differential effects of Cbl isoforms on Egfr signaling in Drosophila. Mech. Dev. 123:450-462.
43. Qiu Y, et al. 2010. A crucial role for RACK1 in the regulation of glucosestimulated IRE1alpha activation in pancreatic beta cells. Sci. Signal. 3:ra7. doi:10.1126/scisignal.2000514.
44. Rao N, Dodge I, Band H. 2002. The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system. J. Leukoc. Biol. 71:753-763.
45. Ren D, Li M, Duan C, Rui L. 2005. Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. Cell Metab. 2:95-104.
46. Ren D, et al. 2007. Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. J. Clin. Invest. 117:397-406.
47. Robertson H, Hime GR, Lada H, Bowtell DD. 2000. A Drosophila analogue of v-Cbl is a dominant-negative oncoprotein in vivo. Oncogene 19:3299-3308.
48. Rulifson EJ, Kim SK, Nusse R. 2002. Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes. Science 296:1118-1120.
49. Saltiel AR, Pessin JE. 2003. Insulin signaling in microdomains of the plasma membrane. Traffic 4:711-716.
50. Schlessinger J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103: 211-225.
51. Schmidt MH, Dikic I. 2005. The Cbl interactome and its functions. Nat. Rev. Mol. Cell Biol. 6:907-918.
52. Sehat B, Andersson S, Girnita L, Larsson O. 2008. Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis. Cancer Res. 68: 5669-5677.
53. Slack C, et al. 2010. Regulation of lifespan, metabolism, and stress responses by the Drosophila SH2B protein, Lnk. PLoS Genet. 6:e1000881. doi:10.1371/journal.pgen.1000881.
54. Song W, et al. 2010. SH2B regulation of growth, metabolism, and longevity in both insects and mammals. Cell Metab. 11:427-437.
55. Swaminathan G, Tsygankov AY. 2006. The Cbl family proteins: ring leaders in regulation of cell signaling. J. Cell. Physiol. 209:21-43.
56. Taguchi A, White MF. 2008. Insulin-like signaling, nutrient homeostasis, and life span. Annu. Rev. Physiol. 70:191-212.
57. Tanaka S, Neff L, Baron R, Levy JB. 1995. Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J. Biol. Chem. 270:14347-14351.
58. Taniguchi CM, Emanuelli B, Kahn CR. 2006. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7:85-96.
59. Tatar M, Bartke A, Antebi A. 2003. The endocrine regulation of aging by insulin-like signals. Science 299:1346-1351.
60. Thien CBF, Langdon WY. 2001. Cbl: many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell Biol. 2:294-307.
61. Wang S, Tulina N, Carlin DL, Rulifson EJ. 2007. The origin of islet-like cells in Drosophila identifies parallels to the vertebrate endocrine axis. Proc. Natl. Acad. Sci. U. S. A. 104:19873-19878.
62. Wang Y, Chen Z, Bergmann A. 2010. Regulation of EGFR and Notch signaling by distinct isoforms of D-cbl during Drosophila development. Dev. Biol. 342:1-10.
63. Wang Y, et al. 2008. Drosophila cbl is essential for control of cell death and cell differentiation during eye development. PLoS One 3:e1447. doi: 10.1371/journal.pone.0001447.
64. Waterman H, Levkowitz G, Alroy I, Yarden Y. 1999. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. J. Biol. Chem. 274:22151-22154.
65. Wetzker R, Bohmer FD. 2003. Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat. Rev. Mol. Cell Biol. 4:651-657.
66. Yang L, et al. 2010. Deficiency in RNA editing enzyme ADAR2 impairs regulated exocytosis. FASEB J. 24:3720-3732.
67. Yoon CH, Lee J, Jongeward GD, Sternberg PW. 1995. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian protooncogene c-cbl. Science 269:1102-1105.
68. Zhang SS, et al. 2009. Coordinated regulation by Shp2 tyrosine phosphatase of signaling events controlling insulin biosynthesis in pancreatic betacells. Proc. Natl. Acad. Sci. U. S. A. 106:7531-7536.
69. Zhang W, Thompson BJ, Hietakangas V, Cohen SM. 2011. MAPK/ERK signaling regulates insulin sensitivity to control glucose metabolism in Drosophila. PLoS Genet. 7:e1002429. doi:10.1371/journal.pgen.1002429.
70. Zhu S, Barshow S, Wildonger J, Jan LY, Jan YN. 2011. Ets transcription factor Pointed promotes the generation of intermediate neural progenitors in Drosophila larval brains. Proc. Natl. Acad. Sci. U. S. A. 108:20615-20620.